PWP
EW icon

Prasad Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Prasad Wealth Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,765
Closed -$294K – 144
2025
Q2 		$294K Hold
3,765
– – 0.09% 95
2025
Q1 		$273K Buy
3,765
+20
+0.5% +$1.43K 0.09% 93
2024
Q4 		$277K Buy
+3,745
New +$262K 0.09% 91

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Prasad Wealth Partners's EW Position: Q3 2025 in Review

Prasad Wealth Partners sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 3,765 shares — an estimated $294K sold.

Prasad Wealth Partners first reported a position in EW in Q4 2024 and held it in 3 quarters. The position peaked at $294K in Q2 2025. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Prasad Wealth Partners reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Prasad Wealth Partners sold 3,765 Edwards Lifesciences shares in Q3 2025, an estimated $294K.
  • Prasad Wealth Partners first reported a position in Edwards Lifesciences in Q4 2024 and held it in 3 quarters.
  • Prasad Wealth Partners's Edwards Lifesciences position peaked at $294K in Q2 2025.
  • 1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Prasad Wealth Partners's 13F filing for Q3 2025, filed 5 Nov 2025.